blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3918071

EP3918071 - CRISPR/CAS-RELATED METHODS AND COMPOSITIONS TARGETING VIRUS GENOMES [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  05.11.2021
Database last updated on 16.09.2024
FormerThe international publication has been made
Status updated on  08.08.2020
Formerunknown
Status updated on  17.03.2020
Most recent event   Tooltip29.01.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Editas Medicine, Inc.
11 Hurley Street
Cambridge, MA 02141 / US
[2021/49]
Inventor(s)01 / DINER, Benjamin, Aryeh
40 Grant Street, 2
Somerville, MA 02145 / US
02 / REYON, Deepak
360 Washington Street, 2
Somerville, MA 02143 / US
[N/P]
Former [2021/49]01 / DINER, Benjamin, Aryeh
Somerville, MA 02145 / US
02 / REYON, Deepak
Somerville, MA 02143 / US
Representative(s)Barker Brettell LLP
100 Hagley Road
Edgbaston
Birmingham B16 8QQ / GB
[2021/49]
Application number, filing date20709392.331.01.2020
[2021/49]
WO2020US16112
Priority number, dateUS201962800231P01.02.2019         Original published format: US 201962800231 P
[2021/49]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020160412
Date:06.08.2020
Language:EN
[2020/32]
Type: A1 Application with search report 
No.:EP3918071
Date:08.12.2021
Language:EN
The application published by WIPO in one of the EPO official languages on 06.08.2020 takes the place of the publication of the European patent application.
[2021/49]
Search report(s)International search report - published on:EP06.08.2020
ClassificationIPC:C12N15/113
[2021/49]
CPC:
C12N15/1133 (EP); C12N15/111 (US); C12N9/22 (US);
C12N2310/20 (EP,US); C12N2320/30 (US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/49]
TitleGerman:CRISPR/CAS-VERWANDTE VERFAHREN UND ZUSAMMENSETZUNGEN, DIE GEGEN VIRUSGENOME GERICHTET SIND[2021/49]
English:CRISPR/CAS-RELATED METHODS AND COMPOSITIONS TARGETING VIRUS GENOMES[2021/49]
French:PROCÉDÉS LIÉS À CRISPR/CAS ET COMPOSITIONS CIBLANT LES GÉNOMES VIRAUX[2021/49]
Entry into regional phase11.08.2021National basic fee paid 
11.08.2021Designation fee(s) paid 
11.08.2021Examination fee paid 
Examination procedure11.08.2021Examination requested  [2021/49]
11.08.2021Date on which the examining division has become responsible
15.03.2022Amendment by applicant (claims and/or description)
Fees paidRenewal fee
27.01.2022Renewal fee patent year 03
27.01.2023Renewal fee patent year 04
29.01.2024Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XYI]WO2015126927  (UNIV DUKE [US], et al) [X] 1-14,17-32,35-50,53-70,73-88,91-111,114-133,136-153,156-162 * claims 1-6, 28, 33, 36, 38, 42, 48 * * the whole document * [Y] 1-162 [I] 15,16,33,34,51,52,71,72,89,90,112,113,134,135,154,155;
 [XYI]WO2017106616  (UNIV COLORADO REGENTS [US], et al) [X] 1-9,12-14,19-27,30-32,37-45,48-50,55,57-65,68-70,75-83,86-88,93-95,97-106,109-111,116-118,120-128,131-133,138-148,151-153,158-160,162 * figure 1; examples 1-3 * * the whole document * [Y] 1-162 [I] 15,16,33,34,51,52,71,72,89,90,112,113,134,135,154,155;
 [XYI]WO2016154016  (UNIV TEMPLE [US]) [X] 1-7,12-14,17,19-25,30-32,35,37-43,48-50,53,55,57-63,68-70,73,75-81,86-88,91,93-95,97-104,109-111,114,116-118,120-126,131-133,136,138-146,151-153,156 * figures 2, 6, 9; example 4 * * the whole document * [Y] 1-162 [I] 15,16,33,34,51,52,71,72,89,90,112,113,134,135,154,155,158-160,162;
 [XYI]WO2017213896  (TEMPLE UNIV - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION [US]) [X] 1-7,12-14,17,19-25,30-32,35,37-43,48-50,53,55,57-63,68-70,73,75-81,86-88,91,93-95,97-104,109-111,114,116-118,120-126,131-133,136,138-146,151-153,156 * figures 5, 6, 11; example 1 * * the whole document * [Y] 1-162 [I] 15,16,33,34,51,52,71,72,89,90,112,113,134,135,154,155,158-160,162;
 [XP]WO2019152868  (EDITAS MEDICINE INC [US]) [XP] 1-162 * page 34 - page 38 * * the whole document *;
 [Y]WO2017075475  (EDITAS MEDICINE INC [US]) [Y] 1-162 * the whole document *;
 [Y]WO2018017925  (HARVARD COLLEGE [US]) [Y] 1-162 * the whole document *;
 [Y]WO2016115355  (UNIV TEMPLE [US]) [Y] 1-162 * the whole document *
by applicantWO2015138510
 WO2016073990
 WO2015070083
    - TSAI et al., Nat. Biotechnol., (20160000), vol. 34, no. 5, page 483
    - CORNISH-BOWDEN A, Nucleic Acids Res., (19850510), vol. 13, no. 9, pages 3021 - 30
    - SANFILIPPO et al., Journal of Virology, (20180000), vol. 92, no. 2, pages 224 - 39
    - PESOLA et al., Journal of Virology, (20050000), vol. 79, no. 23, pages 14516 - 25
    - GRUFFAT, Frontiers in Microbiology, (20160000), vol. 7, page 869
    - MAKAROVA et al., Nat Rev Microbiol., (20110600), vol. 9, no. 6, pages 467 - 477
    - DAVISMAIZELS, PNAS, (20140311), vol. 111, no. 10, pages E924 - 932
    - FRIT et al., DNA Repair, (20140000), vol. 17, pages 81 - 97
    - IYAMAWILSON III, DNA Repair (Amst., (20130800), vol. 12, no. 8, pages 620 - 636
    - KOMOR et al., Nature, (20160519), vol. 533, pages 420 - 424
    - BRINER et al., Molecular Cell, (20141023), vol. 56, no. 2, pages 333 - 339
    - MALI et al., Science, (20130215), vol. 339, no. 6121, pages 823 - 826
    - JIANG et al., Nat Biotechnol., (20130300), vol. 31, no. 3, pages 233 - 239
    - JINEK et al., Science, (20120817), vol. 337, no. 6096, pages 816 - 821
    - HSU et al., Nat Biotechnol., (20130900), vol. 31, no. 9, pages 827 - 832
    - NISHIMASU et al., Cell, (20140227), vol. 156, pages 935 - 949
    - NISHIMASU et al., Cell, (20150827), vol. 162, pages 1113 - 1126
    - ZETSCHE et al., Cell, (20151022), vol. 163, pages 759 - 771
    - MALIHSUFU et al., Nat biotechnol, (20140000), vol. 32, no. 3, pages 279 - 84
    - HEIGWER et al., Nat methods, (20140000), vol. 11, no. 2, pages 122 - 3
    - XIAO A et al., Bioinformatics, (20140000), vol. 30, no. 10, pages 1180 - 1182
    - SHMAKOV et al., Molecular Cell, (20151105), vol. 60, pages 385 - 397
    - RANHSU et al., Cell, (20130912), vol. 154, no. 6, pages 1380 - 1389
    - YAMANO et al., Cell, (20160505), vol. 165, no. 4, pages 949 - 962
    - KLEINSTIVER et al., Nature, (20150723), vol. 523, no. 7561, pages 481 - 5
    - KLEINSTIVER et al., Nat Biotechnol., (20151200), vol. 33, no. 12, pages 1293 - 1298
    - Nature, (20160128), vol. 529, pages 490 - 495
    - ZETSCHE et al., Nat Biotechnol., (20150200), vol. 33, no. 2, pages 139 - 42
    - FINE et al., Sci Rep., (20150701), vol. 5, page 10777
    - GUILINGER et al., Nature Biotechnology, (20140000), vol. 32, pages 577 - 582
    - RICHARDSON et al., Nature Biotechnology, (20160000), vol. 34, pages 339 - 344
    - LEIB, D.A. et al., "The promoter of the latency-associated transcripts of herpes simplex virus type 1 contains a functional cAMP-response element: role of the latency-associated transcripts and cAMP in reactivation of viral latency", Proc Natl Acad Sci U S A, (19910000), vol. 88, no. 1, pages 48 - 52
    - LOIACONO, C.M.R. MYERSW.J. MITCHELL, "Neurons differentially activate the herpes simplex virus type 1 immediate-early gene ICPO and ICP27 promoters in transgenic mice", J Virol, (20020000), vol. 76, no. 5, pages 2449 - 59
    - RUSSELL, T.A.D.C. TSCHARKE, "Lytic Promoters Express Protein during Herpes Simplex Virus Latency", PLoS Pathog, (20160000), vol. 12, no. 6, page e1005729
    - MACKEM, S.B. ROIZMAN, "Structural features of the herpes simplex virus alpha gene 4, 0, and 27 promoter-regulatory sequences which confer alpha regulation on chimeric thymidine kinase genes", J Virol, (19820000), vol. 44, no. 3, pages 939 - 49
    - TAUS, N.S.W.J. MITCHELL, "The transgenic ICP4 promoter is activated in Schwann cells in trigeminal ganglia of mice latently infected with herpes simplex virus type 1", J Virol, (20010000), vol. 75, no. 21, pages 10401 - 8
    - EVERETT, R.D., "The products of herpes simplex virus type 1 (HSV-1) immediate early genes 1, 2 and 3 can activate HSV-1 gene expression in trans", J Gen Virol, (19860000), vol. 67, pages 2507 - 13
    - SU, L.D.M. KNIPE, "Mapping of the transcriptional initiation site of the herpes simplex virus type 1 ICP8 gene in infected and transfected cells", J Virol, (19870000), vol. 61, no. 2, pages 615 - 20
    - HUANG, C.J.E.K. WAGNER, "The herpes simplex virus type 1 major capsid protein (VP5-UL19) promoter contains two cis-acting elements influencing late expression", J Virol, (19940000), vol. 68, no. 9, pages 5738 - 47
    - FLANAGAN, W.M. et al., "Analysis of the herpes simplex virus type 1 promoter controlling the expression of UL38, a true late gene involved in capsid assembly", J Virol, (19910000), vol. 65, no. 2, pages 769 - 86
    - RAMACHANDRAN, S. et al., "Delaying the expression of herpes simplex virus type 1 glycoprotein B (gB) to a true late gene alters neurovirulence and inhibits the gB-CD8+ T-cell response in the trigeminal ganglion", J Virol, (20100000), vol. 84, no. 17, pages 8811 - 20
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.